Scandinavian Biopharma strengthens the organization in Clinical Operations through the recruitment of the pharmacist Christin Hindrika Strid, as Clinical Operations Manager.
The company is in a late-stage clinical development phase and has an ambitious clinical development programme with several ongoing clinical studies for the ETEC vaccine candidate ETVAX. Together with Anna Hill, Christin will be responsible for ensuring that the ongoing and future clinical trials are carried out according to the highest quality standards and in a cost-effective manner. Christin has extensive experience from similar positions at various pharmaceutical companies such as Moberg Pharma, Boehringer Ingelheim, SBL Vaccin and Bayer.
“I feel very excited to be part of the development of this ETEC-vaccine. Preliminary data from the study in Zambia is showing promising immunogenicity results and confirm the favorable safety profile of the vaccine. The analyses of all the participants’ tests are now virtually done, and I am looking forward with excitement towards the first half of 2021 when the results are expected to be completed,” says Christin Hindrika Strid.
Initially Christin will focus on the ETVAX paediatric trial programme in Africa.
“Christin’s experience and competence will suit us well and I am pleased to welcome her to our team. The fact that Christin has previously worked with clinical vaccine studies exactly within this niche field will be very valuable for us,” says Björn Sjöstrand, CEO of Scandinavian Biopharma.
Photo: Scandinavian Biopharma